Edition:
India

Illumina Inc (ILMN.OQ)

ILMN.OQ on NASDAQ Stock Exchange Global Select Market

243.55USD
19 Jan 2018
Change (% chg)

$2.24 (+0.93%)
Prev Close
$241.31
Open
$242.31
Day's High
$244.88
Day's Low
$241.96
Volume
453,597
Avg. Vol
318,640
52-wk High
$248.81
52-wk Low
$156.51

Select another date:

Thu, Jan 11 2018

BRIEF-Illumina Sees Non-GAAP Diluted EPS Attributable To Illumina Stockholders In Range Of $4.50-$4.60 For Fiscal Year 2018

* ILLUMINA INC - SEES NON-GAAP DILUTED EPS ATTRIBUTABLE TO ILLUMINA STOCKHOLDERS IN RANGE OF $4.50 - $4.60 FOR FISCAL YEAR 2018

BRIEF-HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement

* HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT

BRIEF-Luna Dna Announces $2 Mln In Seed Funding Round Included Several Individual Investors And Former Executives From Illumina

* LUNA DNA ANNOUNCES $2 MILLION IN SEED FUNDING; ROUND INCLUDED SEVERAL INDIVIDUAL INVESTORS AND FORMER EXECUTIVES FROM ILLUMINA Source text for Eikon: Further company coverage:

BRIEF-Disney Board Elects Oracle And Illumina CEOs As Directors

* DISNEY BOARD ELECTS ORACLE’S SAFRA CATZ AND ILLUMINA’S FRANCIS A. DESOUZA AS DIRECTORS

BRIEF-Illumina wins infringement suit against Premaitha Health and Ariosa Diagnostics

* Illumina wins infringement suit against Premaitha Health and Ariosa Diagnostics

BRIEF-Illumina announces ‍introduction of its NextSeq 550Dx instrument

* Illumina Inc - ‍introduction of its NextSeq 550Dx instrument, co's second FDA-regulated and CE-IVD marked next-generation sequencing (NGS) system​

BRIEF-Illumina reports Q3 GAAP earnings per share $1.11

* Illumina reports financial results for third quarter of fiscal year 2017

BRIEF-Illumina files new patent infringement suit against Premaitha Health Plc

* Illumina Inc - ‍filed new patent infringement suit against Premaitha Health Plc in High Court of Justice, Chancery Division, Patents Court in UK Source text for Eikon: Further company coverage:

CORRECTED-UPDATE 1-Illumina shares sparkle on strong demand for new gene tech

Aug 2 Shares of Illumina Inc surged nearly 14 percent on Wednesday, a day after the company raised its 2017 revenue forecast on strong demand for its new gene-sequencing technology.

Select another date: